NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,936 | -23.5% | 320 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,142 | +85600.0% | 320 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $6 | +100.0% | 320 | 0.0% | 0.00% | +200.0% |
| Q4 2022 | $3 | -99.9% | 320 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 320 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $3,000 | -25.0% | 320 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $4,000 | -63.6% | 320 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $11,000 | -26.7% | 320 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $15,000 | +7.1% | 320 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,000 | -6.7% | 320 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $15,000 | -11.8% | 320 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $17,000 | +88.9% | 320 | +28.0% | 0.01% | +60.0% |
| Q3 2020 | $9,000 | +12.5% | 250 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $8,000 | +14.3% | 250 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $7,000 | – | 250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |